Health Condition 1: G560- Carpal tunnel syndrome
Conditions
Interventions
Intervention1: Group B (Double injection): Participants in this group will receive two ultrasound-guided injections of 10 mL of 5% dextrose around the median nerve in carpal tunnel, with the second in
Sponsors
Anjali Kumari
Eligibility
Inclusion criteria
Inclusion criteria: Clinical diagnosis of mild to moderate CTS (based on symptoms, nerve conduction study and median nerve cross-sectional area on ultrasound examination) Symptom duration more than 3 months Able to provide informed consent
Exclusion criteria
Exclusion criteria: Previous carpal tunnel surgery Severe CTS (denervation changes on EMG) Other upper limb neuropathies or thoracic outlet syndrome, cervical radiculopathy or brachial plexopathy Coagulopathy or anticoagulant use Previous corticosteroid injection in the affected wrist within 6 months Pregnancy or lactation Systemic diseases such as thyroid disorders, rheumatoid arthritis, diabetes mellitus, chronic renal failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score as measured by numerical pain rating scale (NRS)Timepoint: At baseline, 4, 12, and 24 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Boston carpal tunnel syndrome questionnaire symptom severity score (BCTQ SSS)Timepoint: At baseline, 4, 12, and 24 weeks;Median nerve cross-sectional area at pisiform level on ultrasonographyTimepoint: At baseline, 4, 12, and 24 weeks;Patient satisfaction (Likert scale)Timepoint: At 4, 12, and 24 weeks;Nerve conduction study parameters (distal motor latency, sensory latency, sensory conduction velocity)Timepoint: At baseline and 24 weeks | — |
Countries
India
Contacts
Public ContactAnjali Kumari
Kalinga institute of medical sciences, Bhubaneshwar
Outcome results
None listed